Parkinsons Disease Drug Market Scope And Analysis

  • Report Code : TIPRE00017479
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Parkinsons Disease Drug Market Analysis and Trends by 2031

Buy Now

Parkinsons Disease Drug Market Report Parkinsons Disease Drug Market Size and Share Parkinsons Disease Drug Market Scope and Analysis

Parkinsons Disease Drug Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Mechanism of Action
  • Plastic Dopamine Agonists
  • Anticholinergic
  • MAO-B Inhibitors
  • Amantadine
  • Carbidopa-Levodopa
  • COMT Inhibitors
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck Co Inc
  • Pfizer Inc
  • Impax Laboratories Inc
  • AbbVie Inc
  • Mylan NV
  • Novartis AG
  • Boehringer Ingelheim GmbH
  • Teva Pharmaceuticals Industries Ltd
  • GlaxoSmithKline PLC
  • M Somerset Pharmaceuticals Inc